Dr. Michael Pierce, Director of University of Georgia’s Cancer Center and a Professor of Biochemisty and Molecular Biology, returns to the program to tell us about monoclonal antibodies designed to find and phagocytose cancer cells. There are more than 200 of these cancer-killing drugs are in various stages of FDA approval. The antibodies help your own immune system seek out the cancer cells in your body and destroy them.